This research demonstrated that circ-SNX27 accelerated the progression of HCC by modulating the miR-375/RPN1 axis. This is indicative of circ-SNX27s potential as a target for the treatment of HCC.
Circ-SNX27 sponging miR-375/RPN1 axis contributes to hepatocellular carcinoma progression.